New Insights into the Rational Use of HCV+ Organs Worldwide.
Clicks: 216
ID: 63389
2019
Hepatitis C (HCV) is a worldwide health problem. Effective therapies for HCV infection, coupled with an increase in deceased donors due to the opioid epidemic has led to broader availability and use of HCV infected donor organs, including HCV nucleic acid test positive (NAT+) donors in HCV negative recipients. In this review we discuss the prevalence of HCV infection, trends in the use of HCV infected donors and outcomes for those who receive HCV seropositive or HCV NAT+ donor organs. We discuss management considerations such as Hepatitis B reactivation, selection of the optimal direct acting antiviral regimen and potential complications. We also present a framework for the rational use of HCV infected donor organs in the future.
| Reference Key |
morales2019newclinical
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | Morales, Jose;Sawinski, Deirdre; |
| Journal | clinical transplantation |
| Year | 2019 |
| DOI | 10.1111/ctr.13739 |
| URL | |
| Keywords |
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.